跳至主要内容
临床试验/JPRN-UMIN000020364
JPRN-UMIN000020364已完成未知

Study of evaluating T cells subsets and cytokines in Phase II clinical trial of Tamibarotene (AM80G) for chronic graft-versus-host disease - Th cytokine analysis in Tamibarotene administration for Chronic GVHD

Okayama University Hospital0 个研究点目标入组 18 人开始时间: 2015年12月27日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Mental illness which needs psychiatric medication or are judged by physician as being unsuitable 2. Active, uncontrolled infection (not responding to antibiotics, antifungal or antiviral therapies) 3. Patients with severe liver dysfunction (CTCAE ver.4.0 Grade 3 or more, excepting liver GVHD) 4. Patients with previous experience with Am80 or other retinoid in the past 12 weeks 5. Patients who are allergic or hypersensitive to Am80 or other retinoid. 6. Patients who are pregnant, patients who have possibility of being pregnant, or patients who are breastfeeding. 7. Pulmonary: DLCO <40% or FEV1% <40% 8. Patients with life expectancy of less than 6 months. 9. Patients who are enrolled in other clinical studies in the past 3 months. 10. Other patients who are judged by physician as being unsuitable

研究者

相似试验